{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:21:32Z","timestamp":1792718492516,"version":"4.5.0"},"reference-count":131,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Inflammatory bowel diseases (IBDs), which comprises Crohn\u2019s disease (CD) and ulcerative colitis (UC), is a multifactorial disorder with an as-yet undetermined etiology, with its global incidence rising rapidly, particularly in developing and Western countries. Although the exact etiology remains unclear, recent research implicates genetic predisposition, environmental factors, gut microbiota, and immune responses in the pathogenesis of IBD. Notably, dysbiosis of the gut microbiota\u2014characterized by a reduction in the abundance and diversity of specific bacterial genera\u2014has been suggested as a potential trigger for the onset of IBD, accompanying with dysregulated intestinal mucosal immunity involving in immune cells and nonimmune cells. Understanding and restoring the imbalanced gut microbiota, as well as identifying key bacterial species involved in IBD, are critical for elucidating disease mechanisms and developing therapeutic strategies. In this review, we explore the role of gut microbiota and intestinal mucosal immunity in the pathogenesis of IBD and offers insights into microbiota-centered therapeutic interventions, including probiotics, fecal microbiota transplantation, and microbial metabolites, that aim to modulate the gut microbiota for the treatment of IBD.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1704651","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T06:32:45Z","timestamp":1762842765000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":23,"title":["From pathogenic mechanisms to therapeutic perspectives: a review of gut microbiota and intestinal mucosal immunity in inflammatory bowel disease"],"prefix":"10.3389","volume":"16","author":[{"given":"Tianqi","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-022-00658-y","article-title":"The metabolic nature of inflammatory bowel diseases","volume":"19","author":"Adolph","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-024-00953-0","article-title":"Navigating the complexities of drug development for inflammatory bowel disease","volume":"23","author":"Honap","year":"2024","journal-title":"Nat Rev Drug Discov"},{"key":"B3","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41572-020-0205-x","article-title":"Ulcerative colitis","volume":"6","author":"Kobayashi","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"B4","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41572-020-0156-2","article-title":"Crohn's disease","volume":"6","author":"Roda","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.15389","article-title":"Ulcerative colitis in adults: A review","volume":"330","author":"Gros","year":"2023","journal-title":"JAMA"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies","volume":"390","author":"Ng","year":"2017","journal-title":"Lancet"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjz139","article-title":"Viewpoint: inflammatory bowel diseases among immigrants from low- to high-incidence countries: opportunities and considerations","volume":"14","author":"Agrawal","year":"2020","journal-title":"J Crohns Colitis"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1053\/j.gastro.2019.01.002","article-title":"Past and future burden of inflammatory bowel diseases based on modeling of population-based data","volume":"156","author":"Coward","year":"2019","journal-title":"Gastroenterology"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-318936","article-title":"IBD prevalence in Lothian, Scotland, derived by capture-recapture methodology","volume":"68","author":"Jones","year":"2019","journal-title":"Gut"},{"key":"B10","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41575-020-00360-x","article-title":"The four epidemiological stages in the global evolution of inflammatory bowel disease","volume":"18","author":"Kaplan","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"127660","DOI":"10.1016\/j.micres.2024.127660","article-title":"Gut microbiota and metabolites as predictors of biologics response in inflammatory bowel disease: A comprehensive systematic review","volume":"282","author":"Wang","year":"2024","journal-title":"Microbiol Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2019.07.045","article-title":"Therapeutic opportunities in inflammatory bowel disease: mechanistic dissection of host-microbiome relationships","volume":"178","author":"Plichta","year":"2019","journal-title":"Cell"},{"key":"B13","doi-asserted-by":"publisher","first-page":"101738","DOI":"10.1016\/j.xcrm.2024.101738","article-title":"Integrating multi-omics to unravel host-microbiome interactions in inflammatory bowel disease","volume":"5","author":"Zhang","year":"2024","journal-title":"Cell Rep Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrgastro.2015.186","article-title":"Immunopathogenesis of IBD: current state of the art","volume":"13","author":"de Souza","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1136\/gutjnl-2023-329969","article-title":"Untargeted faecal metabolomics for the discovery of biomarkers and treatment targets for inflammatory bowel diseases","volume":"73","author":"Vich Vila","year":"2024","journal-title":"Gut"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-024-01014-8","article-title":"Short-chain fatty acids: linking diet, the microbiome and immunity","volume":"24","author":"Mann","year":"2024","journal-title":"Nat Rev Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03165-6","article-title":"Western diets and chronic diseases","volume":"30","author":"Adolph","year":"2024","journal-title":"Nat Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-320430","article-title":"Western-type diet influences mortality from necrotising pancreatitis and demonstrates a central role for butyrate","volume":"70","author":"van den Berg","year":"2021","journal-title":"Gut"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-024-00966-0","article-title":"The individual response to antibiotics and diet - insights into gut microbial resilience and host metabolism","volume":"20","author":"Vliex","year":"2024","journal-title":"Nat Rev Endocrinol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2024.06.032","article-title":"Digesting the complex metabolic effects of diet on the host and microbiome","volume":"187","author":"Carmody","year":"2024","journal-title":"Cell"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-320204","article-title":"Interaction between drugs and the gut microbiome","volume":"69","author":"Weersma","year":"2020","journal-title":"Gut"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0963-8","article-title":"Microbiome and health implications for ethnic minorities after enforced lifestyle changes","volume":"26","author":"Keohane","year":"2020","journal-title":"Nat Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s40168-023-01636-5","article-title":"Household environment and animal fecal contamination are critical modifiers of the gut microbiome and resistome in young children from rural Nicaragua","volume":"11","author":"Mills","year":"2023","journal-title":"Microbiome"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2017.88","article-title":"Gut microbiota and IBD: causation or correlation","volume":"14","author":"Ni","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"102845","DOI":"10.1016\/j.autrev.2021.102845","article-title":"Hygiene hypothesis and autoimmune diseases: A narrative review of clinical evidences and mechanisms","volume":"20","author":"Murdaca","year":"2021","journal-title":"Autoimmun Rev"},{"key":"B26","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1053\/j.gastro.2023.09.019","article-title":"Pathobionts in inflammatory bowel disease: origins, underlying mechanisms, and implications for clinical care","volume":"166","author":"Gilliland","year":"2024","journal-title":"Gastroenterology"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.7","article-title":"Dysbiosis and the immune system","volume":"17","author":"Levy","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/s41579-019-0213-6","article-title":"Microbial genes and pathways in inflammatory bowel disease","volume":"17","author":"Schirmer","year":"2019","journal-title":"Nat Rev Microbiol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"14494","DOI":"10.1038\/s41598-023-41182-6","article-title":"Efficacy and safety of fecal microbiota transplantation in the treatment of ulcerative colitis: a systematic review and meta-analysis","volume":"13","author":"Feng","year":"2023","journal-title":"Sci Rep"},{"key":"B30","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1053\/j.gastro.2020.05.060","article-title":"AGA technical review on the role of probiotics in the management of gastrointestinal disorders","volume":"159","author":"Preidis","year":"2020","journal-title":"Gastroenterology"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2021.09.077","article-title":"The future of precision medicine to predict outcomes and control tissue remodeling in inflammatory bowel disease","volume":"162","author":"Lamb","year":"2022","journal-title":"Gastroenterology"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.01.013","article-title":"Are we really vastly outnumbered? Revisiting the ratio of bacterial to host cells in humans","volume":"164","author":"Sender","year":"2016","journal-title":"Cell"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2023.05.006","article-title":"Monocyte regulation by gut microbial signals","volume":"31","author":"Kolypetri","year":"2023","journal-title":"Trends Microbiol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1136\/gutjnl-2024-333378","article-title":"What defines a healthy gut microbiome","volume":"73","author":"Van Hul","year":"2024","journal-title":"Gut"},{"key":"B35","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1741-7015-9-24","article-title":"'Gut health': a new objective in medicine","volume":"9","author":"Bischoff","year":"2011","journal-title":"BMC Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"3863","DOI":"10.1038\/s41467-022-31502-1","article-title":"An expanded reference map of the human gut microbiome reveals hundreds of previously unknown species","volume":"13","author":"Leviatan","year":"2022","journal-title":"Nat Commun"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/nature11550","article-title":"Diversity, stability and resilience of the human gut microbiota","volume":"489","author":"Lozupone","year":"2012","journal-title":"Nature"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2104429118","article-title":"Defining and quantifying the core microbiome: Challenges and prospects","volume":"118","author":"Neu","year":"2021","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2024.09.019","article-title":"A core microbiome signature as an indicator of health","volume":"187","author":"Wu","year":"2024","journal-title":"Cell"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2023.05.032","article-title":"Gut microbiome composition is associated with future onset of crohn's disease in healthy first-degree relatives","volume":"165","author":"Raygoza Garay","year":"2023","journal-title":"Gastroenterology"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.12.004","article-title":"Novel fecal biomarkers that precede clinical diagnosis of ulcerative colitis","volume":"160","author":"Galipeau","year":"2021","journal-title":"Gastroenterology"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3390\/nu10080988","article-title":"The potential of gut commensals in reinforcing intestinal barrier function and alleviating inflammation","volume":"10","author":"Hiippala","year":"2018","journal-title":"Nutrients"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.01145","article-title":"Bacteroides thetaiotaomicron Starch Utilization Promotes Quercetin Degradation and Butyrate Production by Eubacterium ramulus","volume":"10","author":"Rodriguez-Castano","year":"2019","journal-title":"Front Microbiol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"7135","DOI":"10.1038\/s41467-023-42788-0","article-title":"Microbiome and metabolome features in inflammatory bowel disease via multi-omics integration analyses across cohorts","volume":"14","author":"Ning","year":"2023","journal-title":"Nat Commun"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-309940","article-title":"Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD","volume":"66","author":"Lee","year":"2017","journal-title":"Gut"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1016\/j.cmet.2021.07.007","article-title":"Intestinal hypoxia-inducible factor 2alpha regulates lactate levels to shape the gut microbiome and alter thermogenesis","volume":"33","author":"Wu","year":"2021","journal-title":"Cell Metab"},{"key":"B47","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.cmet.2023.03.003","article-title":"Urea cycle activation triggered by host-microbiota maladaptation driving colorectal tumorigenesis","volume":"35","author":"Chen","year":"2023","journal-title":"Cell Metab"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/s41396-020-00848-z","article-title":"Metabolic modeling predicts specific gut bacteria as key determinants for Candida albicans colonization levels","volume":"15","author":"Mirhakkak","year":"2021","journal-title":"ISME J"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04502-w","article-title":"Immune regulation by fungal strain diversity in inflammatory bowel disease","volume":"603","author":"Li","year":"2022","journal-title":"Nature"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003141","article-title":"Point mutations in FimH adhesin of Crohn's disease-associated adherent-invasive Escherichia coli enhance intestinal inflammatory response","volume":"9","author":"Dreux","year":"2013","journal-title":"PloS Pathog"},{"key":"B51","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s40168-021-01135-5","article-title":"Blockage of bacterial FimH prevents mucosal inflammation associated with Crohn's disease","volume":"9","author":"Chevalier","year":"2021","journal-title":"Microbiome"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2007595118","article-title":"Capsular polysaccharide correlates with immune response to the human gut microbe Ruminococcus gnavus","volume":"18","author":"Henke","year":"2021","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B53","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s40168-022-01296-x","article-title":"TLR4 regulates RORgammat(+) regulatory T-cell responses and susceptibility to colon inflammation through interaction with Akkermansia muciniphila","volume":"10","author":"Liu","year":"2022","journal-title":"Microbiome"},{"key":"B54","doi-asserted-by":"publisher","first-page":"2333483","DOI":"10.1080\/19490976.2024.2333483","article-title":"Transplant of microbiota from Crohn's disease patients to germ-free mice results in colitis","volume":"16","author":"Sheikh","year":"2024","journal-title":"Gut Microbes"},{"key":"B55","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s40168-024-01857-2","article-title":"Mouse adaptation of human inflammatory bowel diseases microbiota enhances colonization efficiency and alters microbiome aggressiveness depending on the recipient colonic inflammatory environment","volume":"12","author":"Gray","year":"2024","journal-title":"Microbiome"},{"key":"B56","doi-asserted-by":"publisher","first-page":"2297831","DOI":"10.1080\/19490976.2023.2297831","article-title":"DSS treatment does not affect murine colonic microbiota in absence of the host","volume":"16","author":"Krause","year":"2024","journal-title":"Gut Microbes"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2019.12.025","article-title":"Establishing or exaggerating causality for the gut microbiome: lessons from human microbiota-associated rodents","volume":"180","author":"Walter","year":"2020","journal-title":"Cell"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1053\/j.gastro.2009.12.041","article-title":"In vitro-derived alternatively activated macrophages reduce colonic inflammation in mice","volume":"138","author":"Hunter","year":"2010","journal-title":"Gastroenterology"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-025-01338-y","article-title":"Macrophage-derived VISTA engages with LRIG1 and hinders gut epithelial repair in colitis","author":"Li","year":"2025","journal-title":"Cell Mol Immunol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izab029","article-title":"Human intestinal macrophages are involved in the pathology of both ulcerative colitis and crohn disease","volume":"27","author":"Dharmasiri","year":"2021","journal-title":"Inflammation Bowel Dis"},{"key":"B61","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.autrev.2013.06.004","article-title":"Innate and adaptive immunity in inflammatory bowel disease","volume":"13","author":"Geremia","year":"2013","journal-title":"Autoimmun Rev"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1016\/j.cmet.2023.09.010","article-title":"Metabolic support by macrophages sustains colonic epithelial homeostasis","volume":"35","author":"Fritsch","year":"2023","journal-title":"Cell Metab"},{"key":"B63","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/s41575-023-00871-3","article-title":"Neutrophils: from IBD to the gut microbiota","volume":"21","author":"Danne","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1053\/gast.2001.28021","article-title":"Macrophage-derived IL-18-mediated intestinal inflammation in the murine model of Crohn's disease","volume":"121","author":"Kanai","year":"2001","journal-title":"Gastroenterology"},{"key":"B65","doi-asserted-by":"publisher","first-page":"7567","DOI":"10.3892\/mmr.2018.8833","article-title":"Roseburia intestinalis inhibits interleukin\u221217 excretion and promotes regulatory T cells differentiation in colitis","volume":"17","author":"Zhu","year":"2018","journal-title":"Mol Med Rep"},{"key":"B66","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/imm.12977","article-title":"Peyer's patches-derived CD11b(+) B cells recruit regulatory T cells through CXCL9 in dextran sulphate sodium-induced colitis","volume":"155","author":"Zhiming","year":"2018","journal-title":"Immunology"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1038\/mi.2015.20","article-title":"T regulatory cells and B cells cooperate to form a regulatory loop that maintains gut homeostasis and suppresses dextran sulfate sodium-induced colitis","volume":"8","author":"Wang","year":"2015","journal-title":"Mucosal Immunol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/nri3608","article-title":"Intestinal epithelial cells: regulators of barrier function and immune homeostasis","volume":"14","author":"Peterson","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41586-019-0992-y","article-title":"Colonic epithelial cell diversity in health and inflammatory bowel disease","volume":"567","author":"Parikh","year":"2019","journal-title":"Nature"},{"key":"B70","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1126\/science.abb1590","article-title":"An intercrypt subpopulation of goblet cells is essential for colonic mucus barrier function","volume":"372","author":"Nystr\u00f6m","year":"2021","journal-title":"Science"},{"key":"B71","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/imm.13117","article-title":"Intestinal epithelial cells: at the interface of the microbiota and mucosal immunity","volume":"158","author":"Soderholm","year":"2019","journal-title":"Immunology"},{"key":"B72","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.cell.2019.06.029","article-title":"Intra- and inter-cellular rewiring of the human colon during ulcerative colitis","volume":"178","author":"Smillie","year":"","journal-title":"Cell"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1172\/JCI120330","article-title":"Interpreting heterogeneity in intestinal tuft cell structure and function","volume":"128","author":"Banerjee","year":"2018","journal-title":"J Clin Invest"},{"key":"B74","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.cell.2018.08.067","article-title":"Structural remodeling of the human colonic mesenchyme in inflammatory bowel disease","volume":"175","author":"Kinchen","year":"2018","journal-title":"Cell"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202101817RR","article-title":"NR4A1 modulates intestinal smooth muscle cell phenotype and dampens inflammation-associated intestinal remodeling","volume":"36","author":"Szczepanski","year":"2022","journal-title":"FASEB J"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3001532","article-title":"Colon stroma mediates an inflammation-driven fibroblastic response controlling matrix remodeling and healing","volume":"20","author":"Jasso","year":"2022","journal-title":"PloS Biol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.05.041","article-title":"From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites","volume":"165","author":"Koh","year":"2016","journal-title":"Cell"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1038\/nature12726","article-title":"Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation","volume":"504","author":"Arpaia","year":"2013","journal-title":"Nature"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jafc.3c00278","article-title":"Propionic acid driven by the lactobacillus johnsonii culture supernatant alleviates colitis by inhibiting M1 macrophage polarization by modulating the MAPK pathway in mice","volume":"71","author":"Wu","year":"2023","journal-title":"J Agric Food Chem"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.3390\/nu9090920","article-title":"Therapeutic potential of amino acids in inflammatory bowel disease","volume":"9","author":"Liu","year":"2017","journal-title":"Nutrients"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1021\/pr300139q","article-title":"Quantitative metabolomic profiling of serum, plasma, and urine by (1)H NMR spectroscopy discriminates between patients with inflammatory bowel disease and healthy individuals","volume":"11","author":"Schicho","year":"2012","journal-title":"J Proteome Res"},{"key":"B82","doi-asserted-by":"publisher","first-page":"e31131","DOI":"10.1371\/journal.pone.0031131","article-title":"Novel, objective, multivariate biomarkers composed of plasma amino acid profiles for the diagnosis and assessment of inflammatory bowel disease","volume":"7","author":"Hisamatsu","year":"2012","journal-title":"PloS One"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3390\/cells11152296","article-title":"Gut microbiota-derived tryptophan metabolites maintain gut and systemic homeostasis","volume":"11","author":"Su","year":"2022","journal-title":"Cells"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2018.05.003","article-title":"Gut microbiota regulation of tryptophan metabolism in health and disease","volume":"23","author":"Agus","year":"2018","journal-title":"Cell Host Microbe"},{"key":"B85","doi-asserted-by":"publisher","first-page":"2329147","DOI":"10.1080\/19490976.2024.2329147","article-title":"Indole-3-acetic acid alleviates DSS-induced colitis by promoting the production of R-equol from Bifidobacterium pseudolongum","volume":"16","author":"Li","year":"2024","journal-title":"Gut Microbes"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2015.01.004","article-title":"Bile acid nuclear receptor FXR and digestive system diseases","volume":"5","author":"Ding","year":"2015","journal-title":"Acta Pharm Sinica B"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.829525","article-title":"The emerging role of bile acids in the pathogenesis of inflammatory bowel disease","volume":"13","author":"Thomas","year":"2022","journal-title":"Front Immunol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2025.09.030","article-title":"Gut microbiota: A key player for soluble dietary fiber in regulating inflammatory disease","author":"Qu","year":"2025","journal-title":"J Adv Res"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1172\/JCI193969","article-title":"Emerging concepts and shifting paradigms for understanding the microbial basis of inflammatory bowel diseases","volume":"135","author":"Kennedy","year":"2025","journal-title":"J Clin Invest"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)00966-2","article-title":"Ulcerative colitis","volume":"402","author":"Le Berre","year":"2023","journal-title":"Lancet (London England)"},{"key":"B91","doi-asserted-by":"publisher","first-page":"106146","DOI":"10.1016\/j.phrs.2022.106146","article-title":"Emerging pharmacotherapy for inflammatory bowel diseases","volume":"178","author":"Luo","year":"2022","journal-title":"Pharmacol Res"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0439-x","article-title":"The pros, cons, and many unknowns of probiotics","volume":"25","author":"Suez","year":"2019","journal-title":"Nat Med"},{"key":"B93","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3748\/wjg.v24.i1.5","article-title":"Relationship between intestinal microbiota and ulcerative colitis: Mechanisms and clinical application of probiotics and fecal microbiota transplantation","volume":"24","author":"Shen","year":"2018","journal-title":"World J Gastroenterol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.02.009","article-title":"The microbiome in inflammatory bowel disease: current status and the future ahead","volume":"146","author":"Kostic","year":"2014","journal-title":"Gastroenterology"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1143548","article-title":"Probiotics fortify intestinal barrier function: a systematic review and meta-analysis of randomized trials","volume":"14","author":"Zheng","year":"2023","journal-title":"Front Immunol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2010.11.004","article-title":"A randomised double-blind placebo-controlled trial with Lactobacillus acidophilus La-5 and Bifidobacterium animalis subsp","volume":"5","author":"Wildt","year":"2011","journal-title":"lactis BB-12 maintenance remission ulcerative colitis J Crohn's colitis"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2010.218","article-title":"Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study","volume":"105","author":"Tursi","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/j.chom.2024.07.028","article-title":"Engineered probiotic ameliorates ulcerative colitis by restoring gut microbiota and redox homeostasis","volume":"32","author":"Guo","year":"2024","journal-title":"Cell Host Microbe"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2018.00124","article-title":"Strain-specificity and disease-specificity of probiotic efficacy: A systematic review and meta-analysis","volume":"5","author":"McFarland","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"B100","doi-asserted-by":"publisher","first-page":"20220821","DOI":"10.1515\/biol-2022-0821","article-title":"Probiotics for inflammatory bowel disease: Is there sufficient evidence","volume":"19","author":"Ma","year":"2024","journal-title":"Open Life Sci"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2023.11.007","article-title":"A review on the use of prebiotics in ulcerative colitis","volume":"32","author":"Kennedy","year":"2024","journal-title":"Trends Microbiol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.3390\/nu13103598","article-title":"Prebiotic galactooligosaccharide supplementation in adults with ulcerative colitis: exploring the impact on peripheral blood gene expression, gut microbiota, and clinical symptoms","volume":"13","author":"Wilson","year":"2021","journal-title":"Nutrients"},{"key":"B103","doi-asserted-by":"publisher","first-page":"127449","DOI":"10.1016\/j.micres.2023.127449","article-title":"The potential of paraprobiotics and postbiotics to modulate the immune system: A Review","volume":"275","author":"Mehta","year":"2023","journal-title":"Microbiological Res"},{"key":"B104","doi-asserted-by":"publisher","first-page":"9054","DOI":"10.1021\/acs.jafc.3c03901","article-title":"Postbiotic administration ameliorates colitis and inflammation in rats possibly through gut microbiota modulation","volume":"72","author":"Feng","year":"2024","journal-title":"J Agric Food Chem"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1052644","article-title":"Postbiotic muramyl dipeptide alleviates colitis via activating autophagy in intestinal epithelial cells","volume":"13","author":"You","year":"2022","journal-title":"Front Pharmacol"},{"key":"B106","doi-asserted-by":"publisher","first-page":"134860","DOI":"10.1016\/j.ijbiomac.2024.134860","article-title":"Multi-omics insights into anti-colitis benefits of the synbiotic and postbiotic derived from wheat bran arabinoxylan and Limosilactobacillus reuteri","volume":"278","author":"Zhou","year":"2024","journal-title":"Int J Biol macromolecules"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1039\/D3FO01929B","article-title":"Salidroside alleviates dextran sulfate sodium-induced colitis in mice by modulating the gut microbiota","volume":"14","author":"Liu","year":"2023","journal-title":"Food Funct"},{"key":"B108","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.lfs.2018.01.016","article-title":"Magnolol treatment attenuates dextran sulphate sodium-induced murine experimental colitis by regulating inflammation and mucosal damage","volume":"196","author":"Shen","year":"2018","journal-title":"Life Sci"},{"key":"B109","doi-asserted-by":"publisher","first-page":"108015","DOI":"10.1016\/j.intimp.2021.108015","article-title":"Dioscin prevents DSS-induced colitis in mice with enhancing intestinal barrier function and reducing colon inflammation","volume":"99","author":"Cai","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2013.59","article-title":"Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis","volume":"108","author":"Kassam","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1053\/j.gastro.2015.03.045","article-title":"Findings from a randomized controlled trial of fecal transplantation for patients with ulcerative colitis","volume":"149","author":"Rossen","year":"2015","journal-title":"Gastroenterology"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjx063","article-title":"Faecal microbiota transplantation for inflammatory bowel disease: A systematic review and meta-analysis","volume":"11","author":"Paramsothy","year":"2017","journal-title":"J Crohn's colitis"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(21)00400-3","article-title":"Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): a randomised, double-blind, placebo-controlled trial","volume":"7","author":"Haifer","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1186\/s12866-023-03107-1","article-title":"Fecal microbiota transplantation as a therapy for treating ulcerative colitis: an overview of systematic reviews","volume":"23","author":"Liu","year":"2023","journal-title":"BMC Microbiol"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe1913807","article-title":"Fecal microbiota transplantation for dysbiosis - predictable risks","volume":"381","author":"Blaser","year":"2019","journal-title":"N Engl J Med"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjz006","article-title":"Enterotoxigenic Clostridium perfringens Infection as an Adverse Event After Faecal Microbiota Transplantation in Two Patients With Ulcerative Colitis and Recurrent Clostridium difficile Infection: A Neglected Agent in Donor Screening","volume":"13","author":"Azimirad","year":"2019","journal-title":"J Crohns Colitis"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.3389\/fsysb.2025.1561047","article-title":"The role of probiotics, prebiotics, and synbiotics in the treatment of inflammatory bowel diseases: an overview of recent clinical trials","volume":"5","author":"Yassine","year":"2025","journal-title":"Front Syst Biol"},{"key":"B118","doi-asserted-by":"publisher","first-page":"505878","DOI":"10.1155\/2015\/505878","article-title":"The role of probiotic lactic acid bacteria and bifidobacteria in the prevention and treatment of inflammatory bowel disease and other related diseases: a systematic review of randomized human clinical trials","volume":"2015","author":"Saez-Lara","year":"2015","journal-title":"BioMed Res Int"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1017\/S0029665107005563","article-title":"Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials","volume":"66","author":"Hedin","year":"2007","journal-title":"Proc Nutr Soc"},{"key":"B120","doi-asserted-by":"publisher","first-page":"CD015084","DOI":"10.1002\/14651858.CD015084.pub2","article-title":"Prebiotics for induction and maintenance of remission in ulcerative colitis","volume":"3","author":"Sinopoulou","year":"2024","journal-title":"Cochrane Database Syst Rev"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1007\/s00394-021-02503-5","article-title":"Clinical effects and gut microbiota changes of using probiotics, prebiotics or synbiotics in inflammatory bowel disease: a systematic review and meta-analysis","volume":"60","author":"Zhang","year":"2021","journal-title":"Eur J Nutr"},{"key":"B122","doi-asserted-by":"publisher","first-page":"3165876","DOI":"10.1155\/jnme\/3165876","article-title":"Effects of short chain fatty acid-butyrate supplementation on the disease severity, inflammation, and psychological factors in patients with active ulcerative colitis: A double-blind randomized controlled trial","volume":"2025","author":"Firoozi","year":"2025","journal-title":"J Nutr Metab"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2007.03562.x","article-title":"Review article: the role of butyrate on colonic function","volume":"27","author":"Hamer","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"B124","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1053\/j.gastro.2022.07.052","article-title":"Effect of 5-hydroxytryptophan on fatigue in quiescent inflammatory bowel disease: A randomized controlled trial","volume":"163","author":"Truyens","year":"2022","journal-title":"Gastroenterology"},{"key":"B125","doi-asserted-by":"publisher","first-page":"2395092","DOI":"10.1080\/19490976.2024.2395092","article-title":"Effects of postbiotics on chronic diarrhea in young adults: a randomized, double-blind, placebo-controlled crossover trial assessing clinical symptoms, gut microbiota, and metabolite profiles","volume":"16","author":"Guo","year":"2024","journal-title":"Gut Microbes"},{"key":"B126","doi-asserted-by":"publisher","first-page":"101409","DOI":"10.1016\/j.conctc.2024.101409","article-title":"Clinical study of Jianpi Qingchang decoction in the treatment of ulcerative colitis patients with spleen deficiency and dampness-heat syndrome accompanied by fatigue: Study protocol for a randomized controlled trial","volume":"42","author":"Liu","year":"2024","journal-title":"Contemp Clin Trials Commun"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000021903","article-title":"Clinical evaluation of traditional Chinese medicine on mild active ulcerative colitis: A multi-center, randomized, double-blind, controlled trial","volume":"99","author":"Kou","year":"2020","journal-title":"Med (Baltimore)"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2017.11.024","article-title":"Efficacy of indigo naturalis in a multicenter randomized controlled trial of patients with ulcerative colitis","volume":"154","author":"Naganuma","year":"2018","journal-title":"Gastroenterology"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.20046","article-title":"Effect of fecal microbiota transplantation on 8-week remission in patients with ulcerative colitis: A randomized clinical trial","volume":"321","author":"Costello","year":"2019","journal-title":"JAMA"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izac135","article-title":"Efficacy of fecal microbiota transplantation in the treatment of active ulcerative colitis: A systematic review and meta-analysis of double-blind randomized controlled trials","volume":"29","author":"El Hage Chehade","year":"2023","journal-title":"Inflammation Bowel Dis"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.15598","article-title":"Fecal microbiota transplantation therapy in Crohn's disease: Systematic review","volume":"36","author":"Fehily","year":"2021","journal-title":"J Gastroenterol Hepatol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1704651\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T06:32:47Z","timestamp":1762842767000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1704651\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,11]]},"references-count":131,"alternative-id":["10.3389\/fimmu.2025.1704651"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1704651","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,11]]},"article-number":"1704651"}}